Lexaria Bioscience Corp. (LEXX)
0.5922
-0.02
(-3.06%)
USD |
NASDAQ |
May 15, 16:00
0.5951
0.00 (0.00%)
After-Hours: 20:00
Lexaria Bioscience EPS Diluted (Quarterly) : -0.0593 for Feb. 28, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| CannaPharmaRx, Inc. | -0.0115 |
| InMed Pharmaceuticals, Inc. | -0.7327 |
| Target Group, Inc. (Canada) | -0.0009 |
| Tilray Brands, Inc. | -0.2358 |
| NervGen Pharma Corp. | -0.251 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.453M |
| Revenue (Quarterly) | 0.02M |
| Total Expenses (Quarterly) | 1.47M |
| Enterprise Value | 9.112M |
| Gross Profit Margin (Quarterly) | -33.00% |
| Profit Margin (Quarterly) | -7.26K% |
| Earnings Yield | -80.85% |
| Normalized Earnings Yield | -79.11 |